European Healthcare Growth

The sleeve invests in publicly listed European healthcare companies in biotechnology, medical technology, diagnostics, and specialized services. Targeted companies exhibit clear product scope, niche leadership, and advancing pipelines. The strategy prioritizes high-quality growth underpinned by competitive advantages, recurring revenue, and capital-efficient reinvestment, enabling long-term compounding across subsectors.